Skip to content

Journal · Interventional cardiology · Updated 21 November 2026

Cardiovascular Intervention and Therapeutics

Read Cardiovascular Intervention and Therapeutics articles on DeepDyve. No university library needed.

Cardiovascular Intervention and Therapeutics covers catheter-based heart treatment, from percutaneous coronary intervention and rotational atherectomy to left atrial appendage closure and transcatheter mitral valve repair. It’s an official journal of the Japanese Association of Cardiovascular Intervention and Therapeutics, published by Springer Nature. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Cardiovascular Intervention and Therapeutics
Journal cover

Cardiovascular Intervention and Therapeutics at a glance

Full title
Cardiovascular Intervention and Therapeutics
Abbreviation (NLM)
Cardiovasc Interv Ther
Publisher
Springer Nature
Print ISSN
1868-4300
Online ISSN (eISSN)
1868-4297
Subjects
Cardiology, Therapeutics, Vascular Diseases
Access model
Hybrid (40% free to read in 2026)

Ways to access Cardiovascular Intervention and Therapeutics

40% of the articles Cardiovascular Intervention and Therapeutics published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 40% of Cardiovascular Intervention and Therapeutics articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Cardiovascular Intervention and Therapeutics. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Cardiovascular Intervention and Therapeutics articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Cardiovascular Intervention and Therapeutics’ 2025 Journal Impact Factor is 5.5, and its 5-year Impact Factor is 3.6.

5.5

Journal Impact Factor (2025)

3.6

5-year Impact Factor (2025)

4 days

Median time to first decision

Source: journal metrics on the Cardiovascular Intervention and Therapeutics homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Cardiovascular Intervention and Therapeutics research worth reading

Published January to July 2026. Summaries describe what the authors report.

  1. Open accessCoronary intervention · Calcified lesions

    Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2026

    The CVIT task force on rotational atherectomy updates its expert consensus document, first issued in 2020 and revised in 2023, adding recent evidence and techniques for treating severely calcified lesions during percutaneous coronary intervention.

    Sakakura et al. · Cardiovascular Intervention and Therapeutics, published online January 4, 2026 · DOI 10.1007/s12928-025-01233-3

  2. LitStreamAtrial fibrillation · Left atrial appendage closure

    Left atrial appendage closure after a hospital admission for bleeding in atrial fibrillation patients: frequency, associated factors and prognosis

    Among 1403 anticoagulated atrial fibrillation patients discharged after an intracranial or gastrointestinal bleed in 15 Andalusian hospitals, the authors report that 8.13% had left atrial appendage closure, which was linked to better 24-month overall survival (82% versus 64%).

    Barreiro Mesa et al. · Cardiovascular Intervention and Therapeutics, published online February 3, 2026 · DOI 10.1007/s12928-025-01237-z

  3. LitStreamStructural heart disease · Congenital heart disease

    Feasibility and technical considerations of mitral TEER in adults with surgically repaired congenital heart disease: descriptive cohort of OCEAN-mitral registry

    In the OCEAN-Mitral registry, the authors found 20 of 3,764 transcatheter edge-to-edge repair patients had surgically repaired congenital heart disease, and report 100% acute procedural success, no major intraprocedural complications and short-term outcomes comparable to other patients.

    Funaki et al. · Cardiovascular Intervention and Therapeutics, published online April 22, 2026 · DOI 10.1007/s12928-026-01268-0

  4. LitStreamCoronary intervention · Bifurcation stenting

    Impact of stent size selection during a single stenting with kissing balloon inflation for left main bifurcation lesions

    In 80 OCT-guided single-stent procedures with kissing balloon inflation for left main bifurcations, the authors report that stents larger than the average reference diameter gave better ostial dilation of both the distal main vessel and side branch, with no significant difference in incomplete stent apposition.

    Nakata et al. · Cardiovascular Intervention and Therapeutics, published online July 25, 2026 · DOI 10.1007/s12928-026-01325-8

  5. LitStreamCoronary intervention · Bleeding risk

    Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

    Analyzing 105,525 PCI cases from a Japanese nationwide registry, the authors report that both ischemic and bleeding events rose with higher bleeding risk scores, and that ischemic events (2.0%) were numerically more frequent than bleeding events (1.3%) over one year.

    Asano et al. · Cardiovascular Intervention and Therapeutics, published online March 3, 2026 · DOI 10.1007/s12928-026-01247-5

See every Cardiovascular Intervention and Therapeutics article on DeepDyve

Questions about Cardiovascular Intervention and Therapeutics

How can I read Cardiovascular Intervention and Therapeutics articles without a subscription?

40% of Cardiovascular Intervention and Therapeutics articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Cardiovascular Intervention and Therapeutics articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Cardiovascular Intervention and Therapeutics?

Cardiovascular Intervention and Therapeutics’ NLM (PubMed) abbreviation is Cardiovasc Interv Ther.

What is the ISSN of Cardiovascular Intervention and Therapeutics?

The print ISSN is 1868-4300 and the online ISSN is 1868-4297.

What is the impact factor of Cardiovascular Intervention and Therapeutics?

Cardiovascular Intervention and Therapeutics’ Journal Impact Factor is 5.5 (2025), and its 5-year Impact Factor is 3.6, according to Springer Nature’s published metrics.

Is Cardiovascular Intervention and Therapeutics open access?

Cardiovascular Intervention and Therapeutics is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 55 of 137 Cardiovascular Intervention and Therapeutics articles (40%) carry a Creative Commons license, per Crossref.

Cardiovascular Intervention and Therapeutics articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Cardiovascular Intervention and Therapeutics today

One month free, then less than $2 a day. Cardiovascular Intervention and Therapeutics, plus millions of articles from thousands of journals.

Start free month

Like this: